ghk-cu hair growth study human microneedling peptide clinical studies copper ghk-cu hair growth clinical trial Copper Peptide Microneedling Hair Regrowth

(2015): in studies of drugs approved between 2010 and 2012, just 45 percent of trial participants in small molecule trials were women, but they represented 65 percent of participants in biologic trials (based on Drugs@FDA data)

None of it is from a controlled trial, and the "week" structure below reflects how community sources tend to organize their anecdotes, not a validated schedule

Not a medicine

The landmark 2017 Cell study (Baar MP et al., PMID: 28340339) demonstrated that: (1) FOXO4 protein specifically accumulates in senescent cells where it binds to p53 and prevents p53 from triggering apoptosis (this is the specific mechanism being targeted)